Intertek Pharmaceutical Services
 
Intertek Pharmaceutical Services > Pharma News > Bioclin > Bioclin Acquired by Intertek

Intertek Acquires BioClin Laboratory in Ireland

Bio-analytical and Pharmaceutical Product Analysis Capabilities

February 12, 2008: London UK - Intertek Group plc (Intertek), the leading international provider of quality and safety services to a wide range of industries, has acquired BioClin Research Laboratories Ltd (Bioclin).

Bioclin is one of Ireland’s leading suppliers of contract bio-analysis and analytical research and development, with advanced analytical services including liquid chromatography-tandem mass spectrometry (LC/MS/MS). Bioclin has been serving the local and international pharmaceutical, medical device and drug delivery industry for more than five years. Located in Athlone and with 20 staff, Bioclin is highly regarded for its technical expertise, rigorous compliance programs, and outstanding customer service. The laboratory is Good Laboratory Practice (GLP) certified and is a current Good Manufacturing Practice (cGMP) facility that has been inspected by the IMB.

The acquisition advances Intertek’s strategic growth in expert support services to the global pharmaceutical, medical device and drug delivery industry. Bioclin will operate in Intertek’s Pharmaceutical Services group within its Analytical Services division.

Dr. Andrew Swift, Executive Vice President of Intertek’s Analytical Services Division, comments: “Bioclin has a strong reputation in the industry. Acquiring Bioclin, further expands Intertek’s support globally to the pharmaceutical and related sectors for outsourced R&D and analytical services."

Dr. John Conti-Ramsden, Global Director of Intertek’s Pharmaceutical Services, said: " Bioclin further extends our offering in Europe as well as our global platform supporting pharmaceutical R&D and manufacturing in key locations. Intertek already provides a wide range of testing services to pharmaceutical clients from its laboratories in the United Kingdom, USA, India and Australia.”


Mary Burke, Managing Director and Dr. Brian McKenna, Scientific Director of Bioclin commented jointly: “Joining Intertek will allow Bioclin’s local and international clients to gain from Intertek’s global network and surrounding experts and facilities give. It also gives Bioclin an exciting opportunity to provide our expert services to a wider network of new international clients and markets.”

About Intertek:
Intertek Group plc (FTSE: ITRK) is a leading international provider of quality and safety services to global and local industries. Partnership with Intertek brings increased value to customers’ products and processes, ultimately supporting their success in the global market place. Intertek has the experience, expertise, resources and global reach to support its customers through their network of 21,000 people in more than 100 countries around the world. www.intertek.com

About Intertek’s Pharmaceutical services:
Intertek’s pharmaceutical and speciality chemical laboratories provide a wide range of high-end routine and non-routine laboratory testing services to support pharmaceutical, biotechnology and nanotechnology clients. A growing international network of Intertek laboratories and offices serve clients from a wide range of industries on a global basis with services including laboratory testing, outsourcing, inspection, R&D and process services. Intertek laboratories are ideally suited to support a diverse range of fine chemical, pharmaceutical and biotech activities.

www.intertek-pharma.com

About BioClin:

BioClin a leading GLP certified, FDA and cGMP compliant contract research laboratory, located in Ireland. BioClin integrates its exceptional technical expertise and quality management with a range of related services enabling it to offer a complete range of development services to its clients. The Bioclin team's years experience in the drug delivery and biopharmaceutical industry gives them a unique understanding of clients’ development needs. www.bioclinlabs.com

Intertek Pharmaceutical Services Contacts:

Ireland: Mary Burke, Managing Director

BioClin Research Laboratories
Telephone +353 (90) 6480 400
mary.burke@bioclinlabs.com
www.bioclinlabs.com

UK: John Conti-Ramsden, Ph.D.
Director

Intertek Pharmaceutical Services
Telephone +44 (0) 161-721-2236
john.conti-ramsden@intertek.com

Pharma-Europe@intertek.com

www.intertek-pharma.com

Erik Holladay, Global Marketing Director
Intertek Analytical Services Telephone: +1-713-407-3500 (USA)
testingservices@intertek.com
www.intertek-cb.com

www.intertek.com

 
BioClin Research Laboratories
 

 Contact for more information
Americas Email Enquiries
Europe Email Enquiries
Asia Email Enquires

 Prefer to Call?
Europe: +44 (0) 161 721 5247

Americas: 1 908 534 4445, x669